The Claim
In Japanese adults with type 2 diabetes, treatment with liraglutide significantly reduces post-meal glucose levels compared to linagliptin after two weeks, indicating greater glucose-lowering efficacy despite similar effects on hypoglycemia counter-regulation.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In Japanese adults with type 2 diabetes, liraglutide lowers blood glucose after meals more than linagliptin after two weeks of treatment, while both drugs have similar effects on the body's response to low blood sugar.
See the scientific wording
In Japanese adults with type 2 diabetes, treatment with liraglutide significantly reduces post-meal glucose levels compared to linagliptin after two weeks, indicating greater glucose-lowering efficacy despite similar effects on hypoglycemia counter-regulation.
Liraglutide activates GLP-1 receptors in the pancreas and stomach, which stops the liver from releasing too much sugar after eating and slows down how fast food leaves the stomach, leading to lower blood sugar spikes after meals.
What the research says
1 studyThe study found that liraglutide did a better job than linagliptin at lowering blood sugar after meals in people with type 2 diabetes, even though both drugs worked similarly to protect against low blood sugar.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.